← Back to Search

Dietary Supplement

Active for Health Services Research (AS1 Trial)

N/A
Waitlist Available
Led By Richard B Kreider, PhD
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline (prior to supplementation (pre)), and after 60, 120, 180 and 240 minutes
Awards & highlights

AS1 Trial Summary

This study is evaluating whether tart cherry juice may help reduce the amount of uric acid in the blood.

AS1 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline (prior to supplementation (pre)), and after 60, 120, 180 and 240 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline (prior to supplementation (pre)), and after 60, 120, 180 and 240 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Uric Acid Changes
Secondary outcome measures
Side Effects Assessment

Side effects data

From 2019 Phase 3 trial • 502 Patients • NCT03691831
43%
Application site pain
18%
Application site pallor
10%
Application site erythema
9%
Application site pruritus
8%
Application site scab
5%
Application site erosion
4%
Application site edema
4%
Upper respiratory tract infection
3%
Nasopharyngitis
2%
Application site discoloration
2%
Application site irritation
1%
Sinusitis
1%
Viral upper respiratory tract infection
1%
Contusion
1%
Headache
1%
Hypertension
1%
Application site dermatitis
1%
Application site dryness
1%
Application site paresthesia
1%
Influenza
100%
80%
60%
40%
20%
0%
Study treatment Arm
Active
Vehicle

AS1 Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveExperimental Treatment1 Intervention
Tart Cherry (480 mg)
Group II: PlaceboPlacebo Group1 Intervention
Dextrose (480 mg)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active
2020
Completed Phase 3
~1040

Find a Location

Who is running the clinical trial?

Anderson Global Group, LLCUNKNOWN
Texas A&M UniversityLead Sponsor
140 Previous Clinical Trials
24,082 Total Patients Enrolled
Richard B Kreider, PhDPrincipal InvestigatorTexas A&M University
15 Previous Clinical Trials
949 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
Texas
How old are they?
18 - 65
What site did they apply to?
Exercise & Sport Nutrition Lab - Human Clinical Research Facility
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Anderson Study 1 - Tart Cherry Study
Richard B. Kreider 2020. "Anderson Study 1 - Tart Cherry Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04837274.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top